Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.72 |
| ▸ | HPGD | P15428 | 4/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.72 |
| ▸ | NPC1 | O15118 | 4/20 | 0.58 |
| ▸ | RAB9A | P51151 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 5/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 2/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | PGR | P06401 | 1/20 | 0.54 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29445806 | 1.00 | ALDH1A1 (0.72) | ALDH1A1HPGDCYP3A4MAPK1NPC1 | |
| SCHEMBL28093168 | 0.86 | RAB9A (0.71) | ALDH1A1HPGDCYP3A4MAPK1NPC1 | |
| SCHEMBL28548926 | 0.85 | HPGD (0.58) | ALDH1A1HPGDCYP3A4MAPK1NPC1 | |
| SCHEMBL20286467 | 0.84 | MAOB (0.54) | ALDH1A1HPGDCYP3A4MAPK1NPC1 | |
| SCHEMBL1986986 | 0.84 | ALDH1A1 (0.61) | ALDH1A1HPGDCYP3A4MAPK1NPC1 | |
| Paeonol SCHEMBL3710243 | 0.84 | HPGD (1.00) | ALDH1A1HPGDCYP3A4MAPK1NPC1 | |
| SCHEMBL128781 | 0.84 | CA1 (0.61) | ALDH1A1HPGDCYP3A4MAPK1NPC1 | |
| SCHEMBL29431885 | 0.84 | CA1 (0.61) | ALDH1A1HPGDCYP3A4MAPK1NPC1 | |
| Paeonol SCHEMBL29349833 | 0.84 | HPGD (1.00) | ALDH1A1HPGDCYP3A4MAPK1NPC1 | |
| SCHEMBL6856233 | 0.84 | NPC1 (0.58) | ALDH1A1HPGDCYP3A4MAPK1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 599 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119528857-A | Synthesis method of 5-methoxy-3-benzofuranone | 上海毕臣生化科技有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-114956978-B | Microwave synthesis process of 2-hydroxy-5-methoxy acetophenone | 重庆康普化学工业股份有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-116239622-A | ER beta targeting hydrogen peroxide responsive near infrared fluorescent probe and preparation method and application thereof | 武汉大学 | 2023-06-09 | — | — | CN | claimed |
| CN-114956978-A | Microwave synthesis process of 2-hydroxy-5-methoxyacetophenone | 重庆康普化学工业股份有限公司 | 2022-08-30 | — | — | CN | claimed |
| CN-107082789-B | Method for preparing organic phosphate compound by efficiently esterifying P (O) -OH-containing compound and phenol | 湖南理工学院 | 2020-08-28 | — | — | CN | claimed |
| CN-111187051-A | Autoclaved aerated concrete block brick utilizing construction waste | 佛冈豪鑫环保建材有限公司 | 2020-05-22 | — | — | CN | claimed |
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | claimed |
| EP-0674233-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| CN-122029153-A | Aromatic hydrocarbon receptor modulator compound, and preparation method and application thereof | 德明药泰生物技术（深圳）有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20260092045-A1 | SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2026-04-02 | — | — | US | disclosed |
| US-20250163044-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2025-05-22 | — | — | US | disclosed |
| US-20250163013-A1 | TREATMENT OF GENITOURINARY SYNDROME OF MENOPAUSE | NORDEEN, Steven | 2025-05-22 | — | — | US | disclosed |
| CN-116514788-B | Chromone mTOR inhibitor, and pharmaceutical composition and application thereof | 贵州医科大学 | 2025-05-13 | — | — | CN | disclosed |
| EP-4549424-A1 | NEW LITHIUM EXTRACTING AGENT AND LIQUID ORGANIC MIXTURE THEREOF, AND METHOD FOR EXTRACTING LITHIUM BY MEANS OF EXTRACTION | Beijing Salt Lake Technology Development Company Limited (CN) | 2025-05-07 | — | — | EP | disclosed |
| US-4307020-A | REACTING AN 0-HYDROXYACETOPHENONE WITH A GLYOXYLIC ACID | BAYER AKTIENGESELLSCHAFT (DE) | 1981-12-22 | — | — | US | disclosed |
| US-4285965-A | FUNGICIDES AND INSECTICIDES FOR PLANTS | BAYER AKTIENGESELLSCHAFT (DE) | 1981-08-25 | — | — | US | disclosed |
| US-4281012-A | HYPOLIPEMIC ACTIVITY | ROUSSEL UCLAF (FR) | 1981-07-28 | — | — | US | disclosed |
| EP-0000377-B1 | PROCESS FOR THE PREPARATION OF CHROMONE DERIVATIVES, NEW CHROMONE DERIVATIVES AND THEIR USE AS PLANT-PROTECTING AGENTS | BAYER AG (DE) | 1981-01-21 | — | — | EP | disclosed |
| US-4189498-A | FUNGICIDES, ARTHROPODICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1980-02-19 | — | — | US | disclosed |
| US-4002423-A | Benzofuran derivatives process for their preparation and their use as optical brighteners | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092045-A1 | SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS | TFPI, F3, BTK | ALDH1A1 3179/4885HPGD 3409/4885CYP3A4 433/4885 |
| US-20250163044-A1 | COMPOUNDS | NLN, SLC18A2, PYGB | ALDH1A1 981/4885HPGD 694/4885CYP3A4 759/4885 |
| US-20250163013-A1 | TREATMENT OF GENITOURINARY SYNDROME OF MENOPAUSE | SHBG, GSS, GPER1 | ALDH1A1 2426/4885HPGD 58/4885CYP3A4 2315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.